6533b855fe1ef96bd12b1b8f
RESEARCH PRODUCT
Preclinical evaluation of the anti-CLDN18.2 antibody, IMAB362, in pancreatic carcinoma
Ö. TüreciC. HeinzM. KreuzbergUgur SahinS. WöllR. Mitnacht-kraussubject
0301 basic medicineOncologymedicine.medical_specialtybiologybusiness.industryHematologymedicine.disease03 medical and health sciences030104 developmental biology0302 clinical medicineOncology030220 oncology & carcinogenesisPancreatic cancerInternal medicinebiology.proteinmedicineCA19-9Pancreatic carcinomaAntibodybusinessIMAB362year | journal | country | edition | language |
---|---|---|---|---|
2017-09-01 | Annals of Oncology |